Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2025-12-28 @ 12:12 AM
Study NCT ID:
NCT00121251
Status:
COMPLETED
Last Update Posted:
2021-04-06
First Post:
2005-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2005-07-19
First Submit QC Date:
None
Study First Post Date:
2005-07-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-04-30
Results First Submit QC Date:
None
Results First Post Date:
2021-04-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-17
Last Update Post Date:
2021-04-06
Last Update Post Date Type:
ACTUAL